Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion type Assertion NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_head.
- NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion wasGeneratedBy ECO_0000203 NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_provenance.
- NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion wasDerivedFrom gad-20150221 NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_provenance.
- NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion SIO_000772 20720558 NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_provenance.
- NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion evidence source_evidence_literature NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_provenance.
- NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_provenance.